Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer ConsortiumManish A Shah, Yelena Y Janjigian, Ronald Stoller, et al.
Journal of Gastrointestinal Oncology|July 12, 2023
Perioperative versus total neoadjuvant chemotherapy in gastric cancerJessica Yang, Megan Greally, Vivian E Strong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancerDavid P Kelsen, Katryn A Winter, Leonard L Gunderson, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2022
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinomaRyan H Moy, Megan Greally, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridolManish A Shah, Jeremy Kortmansky, Monica Motwani, et al.
Cancer|May 21, 2011
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancerZsofia K Stadler, Erin Salo-Mullen, Sujata M Patil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2005
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistryKi Young Chung, Jinru Shia, Nancy E Kemeny, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography NonrespondersMegan Greally, Joanne F Chou, Daniela Molena, et al.
Pageof 9